Antimicrobial Spectrum¶
The organism-indexed range over which an antimicrobial shows defined inhibitory or killing activity under specified exposure and test conditions, distinct from guaranteed clinical effectiveness.
Core Idea¶
Antimicrobial spectrum is a relational property of an agent, an organism set, and an activity criterion. It summarizes which organisms are inhibited or killed under declared conditions. Broad and narrow are comparative descriptions whose meaning depends on the reference set and on whether the endpoint is typical class activity or measured isolate susceptibility.
Laboratory spectrum and clinical usefulness are not identical. Resistance varies within species, drug exposure differs by anatomical site, and host, route, dose, diagnosis, and time affect outcomes. Spectrum informs stewardship and empirical reasoning but does not by itself choose treatment.
How would you explain it like I'm…
Which Germs It Stops
Which Germs a Medicine Stops
Agent-Organism Activity Range
Scope of Application¶
- Microbiology. Profiles organism–agent activity across panels and phenotypes.
- Drug development. Compares candidate coverage and resistance gaps.
- Stewardship. Supports narrowing once diagnosis and susceptibility are known.
- Clinical communication. Summarizes likely activity while preserving site and resistance caveats.
Clarity¶
State organism scope, assay standard, endpoint, breakpoint or concentration, and date or resistance context. Avoid universal organism lists and do not turn this descriptive entry into prescribing guidance. Inclusion test: Name the agent, organism reference set, inhibition-or-killing endpoint, exposure conditions, and whether the claim is in vitro, typical, isolate-specific, or clinical. Exclusion test: Exclude drug potency stated without organisms, coverage lists detached from resistance prevalence, and treatment recommendations inferred from a broad-spectrum label alone. Nearest boundary: Susceptibility describes a particular organism–agent result under criteria; spectrum summarizes activity across a range of organisms. Exit condition: The claim exits the abstraction when organism range or activity criterion is unspecified, or when clinical effectiveness is asserted solely from laboratory coverage.
Manages Complexity¶
Spectrum compresses many organism–agent observations into a usable coverage profile. The abstraction remains safe only when isolate variation, exposure, and clinical translation are not hidden by one broad label.
Abstract Reasoning¶
- Define agent and organism reference population.
- Choose standardized inhibition or killing endpoints.
- Measure or compile activity under comparable conditions.
- Stratify by species and resistance phenotype.
- Keep clinical site and exposure as a separate translation step.
Knowledge Transfer¶
The profiling structure transfers across antibacterial, antifungal, antiviral, and other agents if organism and endpoint conventions are restated. Category labels do not transfer unchanged across those fields.
Relationships to Other Abstractions¶
Current abstraction Antimicrobial Spectrum Domain-specific
Parents (1) — more general patterns this builds on
-
Antimicrobial Spectrum is a kind of Applicability Scope Prime
An Antimicrobial Spectrum is an Applicability Scope delimiting the organisms against which an antimicrobial has defined activity under stated exposure and test conditions.
Hierarchy path (1) — routes to 1 parentless root
- Antimicrobial Spectrum → Applicability Scope → Boundary
Neighborhood in Abstraction Space¶
Antimicrobial Spectrum sits in a moderately populated region (48th percentile for distinctiveness): it has near-neighbors but no dense thicket of look-alikes.
Family — Applied Assessment Frameworks & Practices (26 abstractions)
Nearest neighbors
- Cell culture assay — 0.89
- Internal Standard — 0.86
- Biomarker (medicine) — 0.86
- Enzyme assay — 0.86
- Endosymbiosis — 0.85
Computed from structural-signature embeddings · 2026-10-08